Key Takeaways
- • Thoma Bravo agreed to acquire NextGen Healthcare for $1.8 billion in enterprise value, taking the healthcare software provider private at $23.95 per share, representing a 46% premium to an earlier reported price.
- • The deal underscores continued private-equity appetite for healthcare software assets, with Thoma Bravo targeting a provider serving medical practices, hospitals, and healthcare organizations with EHR and practice management solutions.
- • NextGen Healthcare's privatization removes the company from public markets, signaling Thoma Bravo's confidence in operational improvements and potential portfolio optimization under private ownership.
Summary
Thoma Bravo, a prominent middle-market private-equity firm, has agreed to take healthcare software provider NextGen Healthcare private in a transaction valued at $1.8 billion including debt. The acquisition price of $23.95 per share reflects a substantial 46% premium relative to an earlier reported valuation, demonstrating competitive interest in the healthcare software sector and the asset's strategic value to investors.
NextGen Healthcare is a software provider serving healthcare organizations including medical practices, hospitals, and other providers with electronic health record (EHR) systems, practice management platforms, and related health IT solutions. The company's privatization represents Thoma Bravo's strategic bet on healthcare IT consolidation and operational improvements achievable outside the public markets.
The transaction highlights broader private-equity momentum in healthcare technology. The sector has attracted significant capital deployment as healthcare providers seek digital transformation and operational efficiency solutions. Thoma Bravo's acquisition of NextGen Healthcare adds to the firm's healthcare-focused portfolio and reflects investor conviction that margin expansion and strategic initiatives can be accelerated under private ownership without quarterly earnings pressures.
The deal closure is expected in the near term, transitioning NextGen Healthcare from a publicly traded company to a privately-held Thoma Bravo portfolio asset. This acquisition fits a pattern of strategic consolidation in healthcare IT where private-equity firms pursue scale opportunities and operational leverage across software platforms serving the fragmented U.S. healthcare delivery system.
NextGen Healthcare is a software provider serving healthcare organizations including medical practices, hospitals, and other providers with electronic health record (EHR) systems, practice management platforms, and related health IT solutions. The company's privatization represents Thoma Bravo's strategic bet on healthcare IT consolidation and operational improvements achievable outside the public markets.
The transaction highlights broader private-equity momentum in healthcare technology. The sector has attracted significant capital deployment as healthcare providers seek digital transformation and operational efficiency solutions. Thoma Bravo's acquisition of NextGen Healthcare adds to the firm's healthcare-focused portfolio and reflects investor conviction that margin expansion and strategic initiatives can be accelerated under private ownership without quarterly earnings pressures.
The deal closure is expected in the near term, transitioning NextGen Healthcare from a publicly traded company to a privately-held Thoma Bravo portfolio asset. This acquisition fits a pattern of strategic consolidation in healthcare IT where private-equity firms pursue scale opportunities and operational leverage across software platforms serving the fragmented U.S. healthcare delivery system.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.